BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 27776914)

  • 1. The fate of small-size pericardial heart valve prostheses in an older patient population.
    De Paulis R; D'Aleo S; Bellisario A; Salica A; Weltert LP; Scaffa R; Wolf LG; Maselli D; Di Mauro M
    J Thorac Cardiovasc Surg; 2017 Jan; 153(1):31-39.e2. PubMed ID: 27776914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fate of aortic bioprostheses: An 18-year experience.
    Piccardo A; Blossier JD; Le Guyader A; Orsel I; Sekkal S; Cornu E; Laskar M
    J Thorac Cardiovasc Surg; 2016 Mar; 151(3):754-761.e1. PubMed ID: 26651959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Durability after aortic valve replacement with the Mitroflow versus the Perimount pericardial bioprosthesis: a single-centre experience in 2393 patients.
    Nielsen PH; Hjortdal V; Modrau IS; Jensen H; Kimose HH; Terp K; Poulsen SH; Smerup M; Nielsen SL
    Eur J Cardiothorac Surg; 2016 Jun; 49(6):1705-10. PubMed ID: 26984983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term results of the Mitroflow aortic pericardial bioprosthesis in over 800 patients: limited durability and mechanisms of dysfunction.
    Ius F; Schulz J; Roumieh M; Fleissner F; Ismail I; Tudorache I; Warnecke G; Martens A; Shrestha M; Boethig D; Haverich A; Cebotari S
    Eur J Cardiothorac Surg; 2017 Aug; 52(2):264-271. PubMed ID: 28838100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early structural valve deterioration and reoperation associated with the mitroflow aortic valve.
    Axtell AL; Chang DC; Melnitchouk S; Jassar AS; Tolis G; Villavicencio MA; Sundt TM; D'Alessandro DA
    J Card Surg; 2018 Dec; 33(12):778-786. PubMed ID: 30525247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early structural valve deterioration of Mitroflow aortic bioprosthesis: mode, incidence, and impact on outcome in a large cohort of patients.
    Sénage T; Le Tourneau T; Foucher Y; Pattier S; Cueff C; Michel M; Serfaty JM; Mugniot A; Périgaud C; Carton HF; Al Habash O; Baron O; Roussel JC
    Circulation; 2014 Dec; 130(23):2012-20. PubMed ID: 25355912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of Mitroflow bioprosthesis structural valve deterioration on cardiac morbidity.
    Waziri F; Karunanithi Z; Løgstrup BB; Hjortdal V; Nielsen PH; Poulsen SH
    J Cardiothorac Surg; 2019 Mar; 14(1):62. PubMed ID: 30885227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural valve deterioration in the Mitroflow biological heart valve prosthesis.
    Issa IF; Poulsen SH; Waziri F; Torp Pedersen C; Nielsen PH; Riber L; Dahl JS; Søgaard P; Nørgaard MA; Møller JE
    Eur J Cardiothorac Surg; 2018 Jan; 53(1):136-142. PubMed ID: 29029140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ten-year results of aortic valve replacement with first-generation Mitroflow bioprosthesis: is early degeneration a structural or a technical issue?
    Lootens L; Verbeke J; Martens T; Philipsen T; Caes F; Van Belleghem Y; Van Nooten G; François K; De Bacquer D; Bove T
    Eur J Cardiothorac Surg; 2017 Aug; 52(2):272-278. PubMed ID: 28430883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitroflow LXA structural deterioration following aortic valve replacement: a single-center experience.
    Zannis K; Diplaris K; Monin JL; Khelil N; Debauchez M; Dervanian P; Lansac E; Czirom D; Noghin M; Mankoubi L; Amabile N
    J Cardiovasc Surg (Torino); 2018 Oct; 59(5):746-752. PubMed ID: 29786406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seventeen-year clinical results of 1,037 Mitroflow pericardial heart valve prostheses in the aortic position.
    Yankah CA; Schubel J; Buz S; Siniawski H; Hetzer R
    J Heart Valve Dis; 2005 Mar; 14(2):172-9; discussion 179-80. PubMed ID: 15792176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural valve deterioration of bioprosthetic aortic valves: An underestimated complication.
    Sénage T; Gillaizeau F; Le Tourneau T; Marie B; Roussel JC; Foucher Y
    J Thorac Cardiovasc Surg; 2019 Apr; 157(4):1383-1390.e5. PubMed ID: 30415900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stentless vs Stented Aortic Valve Bioprostheses in the Small Aortic Root.
    Wollersheim LW; Li WW; Kaya A; Bouma BJ; Driessen AH; van Boven WJ; van der Meulen J; de Mol BA
    Semin Thorac Cardiovasc Surg; 2016 Summer; 28(2):390-397. PubMed ID: 28043449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early calcification of the aortic Mitroflow pericardial bioprosthesis in the elderly.
    Alvarez JR; Sierra J; Vega M; Adrio B; Martinez-Comendador J; Gude F; Martinez-Cereijo J; Garcia J
    Interact Cardiovasc Thorac Surg; 2009 Nov; 9(5):842-6. PubMed ID: 19679611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left ventricular mass regression after aortic valve replacement with the new Mitroflow 12A pericardial bioprosthesis.
    García-Bengochea J; Sierra J; González-Juanatey JR; Rubio J; Vega M; Fernández AL; Sánchez D
    J Heart Valve Dis; 2006 May; 15(3):446-51; discussion 451-2. PubMed ID: 16784087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitroflow aortic pericardial bioprosthesis--clinical performance.
    Jamieson WR; Koerfer R; Yankah CA; Zittermann A; Hayden RI; Ling H; Hetzer R; Dolman WB
    Eur J Cardiothorac Surg; 2009 Nov; 36(5):818-24. PubMed ID: 19700338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Outcomes and Durability of the Mitroflow Aortic Bioprosthesis.
    Mosquera VX; Bouzas-Mosquera A; Velasco-García C; Muñiz J; Estévez-Cid F; Portela-Torron F; Herrera-Noreña JM; Cuenca-Castillo JJ
    J Card Surg; 2016 May; 31(5):264-73. PubMed ID: 26991888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real Structural Valve Deterioration of the Mitroflow Aortic Prosthesis: Competing Risk Analysis.
    Díaz R; Hernández-Vaquero D; Silva J; Pascual I; de la Hera JM; León V; Martín M; Barriales V; Colunga S; Del Valle R; Morís C
    Rev Esp Cardiol (Engl Ed); 2017 Dec; 70(12):1074-1081. PubMed ID: 28465144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient-prosthesis mismatch in patients undergoing bioprosthetic aortic valve implantation increases risk of reoperation for structural valve deterioration.
    Urso S; Calderón P; Sadaba R; Mahillo I; Tuñón J; Aldamiz G; Fraile J
    J Card Surg; 2014 Jul; 29(4):439-44. PubMed ID: 24773571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relation of structural valve deterioration to adverse remodelling and outcome in patients with biological heart valve prostheses.
    Issa IF; Dahl JS; Poulsen SH; Waziri F; Pedersen CT; Riber L; Søgaard P; Møller JE
    Eur Heart J Cardiovasc Imaging; 2021 Jan; 22(1):82-91. PubMed ID: 31942609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.